These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30680153)

  • 61. CDC's Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network.
    Turner NA; Krishnan J; Nelson A; Polage CR; Sinkowitz-Cochran RL; Fike L; Kuhar DT; Kutty PK; Snyder RL; Anderson DJ
    JAMA Netw Open; 2024 Mar; 7(3):e243846. PubMed ID: 38536174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A global to local genomics analysis of Clostridioides difficile ST1/RT027 identifies cryptic transmission events in a northern Arizona healthcare network.
    Williamson CHD; Stone NE; Nunnally AE; Hornstra HM; Wagner DM; Roe CC; Vazquez AJ; Nandurkar N; Vinocur J; Terriquez J; Gillece J; Travis J; Lemmer D; Keim P; Sahl JW
    Microb Genom; 2019 Jul; 5(7):. PubMed ID: 31107202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of a stewardship intervention focused on reducing unnecessary use of non-
    Hecker MT; Son AH; Alhmidi H; Wilson BM; Wiest PM; Donskey CJ
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):216-218. PubMed ID: 31843033
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent developments in the management of recurrent Clostridioides difficile infection.
    Mendo-Lopez R; Villafuerte-Gálvez J; White N; Mahoney MV; Kelly CP; Alonso CD
    Anaerobe; 2020 Apr; 62():102108. PubMed ID: 31606481
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence and economic burden of
    Pereira JA; McGeer A; Tomovici A; Selmani A; Chit A
    CMAJ Open; 2020; 8(1):E16-E25. PubMed ID: 32001435
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection.
    Barker AK; Scaria E; Safdar N; Alagoz O
    JAMA Netw Open; 2020 Aug; 3(8):e2012522. PubMed ID: 32789514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of fidaxomicin use in community hospitals after a clinical guideline change at a large health system and opportunities for stewardship.
    Khadem TM; Nguyen MH; Bariola JR
    Infect Control Hosp Epidemiol; 2023 Feb; 44(2):312-314. PubMed ID: 35067241
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile Infection in the USA.
    Lodise T; Guo A; Yang M; Cook EE; Song W; Yang D; Wang Q; Zhao A; Bochan M
    Adv Ther; 2023 Jun; 40(6):2784-2800. PubMed ID: 37093359
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions.
    Nanwa N; Sander B; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Kwong JC
    PLoS One; 2017; 12(3):e0172410. PubMed ID: 28257438
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlation between antibiotic consumption and the incidence of healthcare facility-onset Clostridioides difficile infection: a retrospective chart review and analysis.
    Yun JH; Park GE; Ki HK
    Antimicrob Resist Infect Control; 2021 Aug; 10(1):117. PubMed ID: 34362442
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting.
    Champredon D; Shoukat A; Moghadas SM
    Vaccine; 2020 Mar; 38(11):2585-2591. PubMed ID: 32014268
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary prevention of Clostridium difficile infections - how difficult can it be?
    McFarland LV
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):507-521. PubMed ID: 28347160
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
    Branch-Elliman W; Ripollone JE; O'Brien WJ; Itani KMF; Schweizer ML; Perencevich E; Strymish J; Gupta K
    PLoS Med; 2017 Jul; 14(7):e1002340. PubMed ID: 28692690
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Application of consolidated framework for implementation research to improve Clostridioides difficile infection management in district hospitals.
    Legenza L; Coetzee R; Rose WE; Esack T; Crombie K; Mina M; Safdar N; Barnett SG
    Res Social Adm Pharm; 2022 Dec; 18(12):4100-4111. PubMed ID: 35981939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
    Baur D; Gladstone BP; Burkert F; Carrara E; Foschi F; Döbele S; Tacconelli E
    Lancet Infect Dis; 2017 Sep; 17(9):990-1001. PubMed ID: 28629876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.